Structural basis of bacterial defense against g-type lysozyme-based innate immunity

Gram-negative bacteria can produce specific proteinaceous inhibitors to defend themselves against the lytic action of host lysozymes. So far, four different lysozyme inhibitor families have been identified. Here, we report the crystal structure of the Escherichia coli periplasmic lysozyme inhibitor of g-type lysozyme (PliG-Ec) in complex with Atlantic salmon g-type lysozyme (SalG) at a resolution of 0.95 Å, which is exceptionally high for a complex of two proteins. The structure reveals for the first time the mechanism of g-type lysozyme inhibition by the PliG family. The latter contains two specific conserved regions that are essential for its inhibitory activity. The inhibitory complex formation is based on a double ‘key-lock’ mechanism. The first key-lock element is formed by the insertion of two conserved PliG regions into the active site of the lysozyme. The second element is defined by a distinct pocket of PliG accommodating a lysozyme loop. Computational analysis indicates that this pocket represents a suitable site for small molecule binding, which opens an avenue for the development of novel antibacterial agents that suppress the inhibitory activity of PliG.

[1]  A. Aertsen,et al.  Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme , 2010, Cellular and Molecular Life Sciences.

[2]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[3]  Chris W. Michiels,et al.  Lysozymes in the animal kingdom , 2010, Journal of Biosciences.

[4]  D. Svergun,et al.  CRYSOL : a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates , 1995 .

[5]  Kimberly M. Davis,et al.  Modifications to the Peptidoglycan Backbone Help Bacteria To Establish Infection , 2010, Infection and Immunity.

[6]  Sergei V Strelkov,et al.  Structural characterization of the PliG lysozyme inhibitor family. , 2012, Journal of structural biology.

[7]  Long Yu,et al.  Characterization and expression of HLysG2, a basic goose-type lysozyme from the human eye and testis. , 2011, Molecular immunology.

[8]  B. Brandsdal,et al.  Thermodynamics and structure of a salmon cold active goose-type lysozyme. , 2010, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[9]  Christoph Gille,et al.  STRAP: editor for STRuctural Alignments of Proteins , 2001, Bioinform..

[10]  D. Chourrout,et al.  Urochordates carry multiple genes for goose-type lysozyme and no genes for chicken- or invertebrate-type lysozymes , 2003, Cellular and Molecular Life Sciences CMLS.

[11]  T. Ueda,et al.  Crystal Structure of Tapes japonica Lysozyme with Substrate Analogue , 2007, Journal of Biological Chemistry.

[12]  A. Voet,et al.  Guards of the great wall: bacterial lysozyme inhibitors. , 2012, Trends in microbiology.

[13]  J. A. Rupley,et al.  Productive and unproductive lysozyme-chitosaccharide complexes. Equilibrium measurements. , 1975, Biochemistry.

[14]  Marc De Maeyer,et al.  Structure based discovery of small molecule suppressors targeting bacterial lysozyme inhibitors. , 2011, Biochemical and biophysical research communications.

[15]  A. Aertsen,et al.  A New Family of Lysozyme Inhibitors Contributing to Lysozyme Tolerance in Gram-Negative Bacteria , 2008, PLoS pathogens.

[16]  Jean-Michel Claverie,et al.  Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria , 2007, Proceedings of the National Academy of Sciences.

[17]  F. Cabello,et al.  Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. , 2006, Environmental microbiology.

[18]  C Abergel,et al.  Escherichia coli ykfE ORFan Gene Encodes a Potent Inhibitor of C-type Lysozyme* , 2001, The Journal of Biological Chemistry.

[19]  R. Helland,et al.  Crystal structures of g-type lysozyme from Atlantic cod shed new light on substrate binding and the catalytic mechanism , 2009, Cellular and Molecular Life Sciences.

[20]  M. Weiss,et al.  On the routine use of soft X-rays in macromolecular crystallography. , 2001, Acta crystallographica. Section D, Biological crystallography.

[21]  B. Matthews,et al.  The refined structures of goose lysozyme and its complex with a bound trisaccharide show that the "goose-type" lysozymes lack a catalytic aspartate residue. , 1995, Journal of molecular biology.

[22]  P. Kyomuhendo,et al.  A cold-active salmon goose-type lysozyme with high heat tolerance , 2007, Cellular and Molecular Life Sciences.

[23]  P. Evans,et al.  Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.

[24]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[25]  X. Barril,et al.  Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. , 2010, Journal of medicinal chemistry.

[26]  S. Withers,et al.  Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate , 2001, Nature.

[27]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[28]  R. Henderson,et al.  Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. , 2003, Journal of molecular biology.

[29]  G. Baggerman,et al.  Identification of a bacterial inhibitor against g-type lysozyme , 2011, Cellular and Molecular Life Sciences.

[30]  Peter V. Konarev,et al.  ATSAS 2.1 – towards automated and web-supported small-angle scattering data analysis , 2007 .

[31]  W. Y. Wahlgren,et al.  The Catalytic Aspartate Is Protonated in the Michaelis Complex Formed between Trypsin and an in Vitro Evolved Substrate-like Inhibitor , 2010, The Journal of Biological Chemistry.

[32]  Ji-won Park,et al.  Structural basis for the recognition of lysozyme by MliC, a periplasmic lysozyme inhibitor in Gram-negative bacteria. , 2009, Biochemical and biophysical research communications.

[33]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[34]  S. Kawamura,et al.  Experimental verification of the crucial roles of Glu73 in the catalytic activity and structural stability of goose type lysozyme. , 2006, Journal of biochemistry.

[35]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[36]  A. Aertsen,et al.  Purification of Ivy, a lysozyme inhibitor from Escherichia coli, and characterisation of its specificity for various lysozymes , 2005 .

[37]  P. Andrew Karplus,et al.  Linking Crystallographic Model and Data Quality , 2012, Science.

[38]  Andrea Schmidt,et al.  On the routine use of soft X-rays in macromolecular crystallography. Part IV. Efficient determination of anomalous substructures in biomacromolecules using longer X-ray wavelengths. , 2007, Acta crystallographica. Section D, Biological crystallography.

[39]  S. Strelkov,et al.  Molecular basis of bacterial defense against host lysozymes: X-ray structures of periplasmic lysozyme inhibitors PliI and PliC. , 2011, Journal of molecular biology.

[40]  Y. Honda,et al.  Substrate binding subsites of chitinase from barley seeds and lysozyme from goose egg white. , 1998, Biochimica et biophysica acta.

[41]  B. Matthews,et al.  Structural basis of the conversion of T4 lysozyme into a transglycosidase by reengineering the active site. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Bernhard Rupp,et al.  Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein–nucleic acid complex crystals , 2003, Protein science : a publication of the Protein Society.

[43]  T. Chiller,et al.  Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. , 2004, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[44]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[45]  B. Brandsdal,et al.  Structural evidence for lack of inhibition of fish goose-type lysozymes by a bacterial inhibitor of lysozyme , 2008, Journal of molecular modeling.

[46]  J. Kirsch,et al.  Site-directed mutagenesis of the catalytic residues Asp-52 and Glu-35 of chicken egg white lysozyme. , 1989, Proceedings of the National Academy of Sciences of the United States of America.